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ABSTRACT
This clinical report reviews the nutritional options during pregnancy, lactation,
and the first year of life that may affect the development of atopic disease (atopic
dermatitis, asthma, food allergy) in early life. It replaces an earlier policy statement
from the American Academy of Pediatrics that addressed the use of hypoallergenic
infant formulas and included provisional recommendations for dietary manage-
ment for the prevention of atopic disease. The documented benefits of nutritional
intervention that may prevent or delay the onset of atopic disease are largely
limited to infants at high risk of developing allergy (ie, infants with at least 1
first-degree relative [parent or sibling] with allergic disease). Current evidence
does not support a major role for maternal dietary restrictions during pregnancy or
lactation. There is evidence that breastfeeding for at least 4 months, compared with
feeding formula made with intact cow milk protein, prevents or delays the occur-
rence of atopic dermatitis, cow milk allergy, and wheezing in early childhood. In
studies of infants at high risk of atopy and who are not exclusively breastfed for 4
to 6 months, there is modest evidence that the onset of atopic disease may be
delayed or prevented by the use of hydrolyzed formulas compared with formula
made with intact cow milk protein, particularly for atopic dermatitis. Comparative
studies of the various hydrolyzed formulas also indicate that not all formulas have
the same protective benefit. There is also little evidence that delaying the timing
of the introduction of complementary foods beyond 4 to 6 months of age prevents
the occurrence of atopic disease. At present, there are insufficient data to docu-
ment a protective effect of any dietary intervention beyond 4 to 6 months of age
for the development of atopic disease.
INTRODUCTION
Over the past several decades, the incidence of atopic diseases such as asthma,
atopic dermatitis, and food allergies has increased dramatically. Among children
up to 4 years of age, the incidence of asthma has increased 160%, and the
incidence of atopic dermatitis has increased twofold to threefold.1 The incidence of
peanut allergy has also doubled in the past decade.2 Thus, atopic diseases increas-
ingly are a problem for clinicians who provide health care to children.
It has been recognized that early childhood events, including diet, are likely to
be important in the development of both childhood and adult diseases. This clinical
report will review the nutritional options during pregnancy, lactation, and the first
year of life that may or may not affect the development of atopic disease. Although
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atopic diseases have a clear genetic basis, environmental
factors, including early infant nutrition, may have an
important influence on their development and, thus,
present an opportunity to prevent or delay the onset of
the disease. This clinical report replaces an earlier policy
statement3 from the American Academy of Pediatrics
(AAP) that addressed the use of hypoallergenic infant
formulas and included provisional recommendations for
dietary management for the prevention of atopic dis-
ease. This report is not directed at the treatment of atopic
disease once an infant or child has developed specific
atopic symptoms.
DEFINITIONS
The following definitions are used throughout this clin-
ical report (adapted from work by Muraro et al4):
Allergy: A hypersensitivity reaction initiated by im-
munologic mechanisms.
Atopy: A personal or familial tendency to produce
immunoglobulin E (IgE) antibodies in response to
low-dose allergens, confirmed by a positive skin-prick
test result.
Atopic disease: Clinical disease characterized by ato-
py; typically refers to atopic dermatitis, asthma, aller-
gic rhinitis, and food allergy. This report will be lim-
ited to the discussion of conditions for which
substantial information is available in the medical
literature.
Atopic dermatitis (eczema): A pruritic, chronic in-
flammatory skin disease that commonly presents dur-
ing early childhood and is often associated with a
personal or family history of other atopic diseases.
Asthma: An allergic-mediated response in the bron-
chial airways that is verified by the variation in lung
function (measured by spirometry) either spontane-
ously or after bronchodilating drugs.
Cow milk allergy: An immunologically mediated hy-
persensitivity reaction to cow milk, including IgE-
mediated and/or non––IgE-mediated allergic reac-
tions.
Food allergy: An immunologically mediated hyper-
sensitivity reaction to any food, including IgE-medi-
ated and/or non––IgE-mediated allergic reactions.
Hypoallergenic: Reduced allergenicity or reduced
ability to stimulate an IgE response and induce IgE-
mediated reactions.
Infants at high risk of developing allergy: Infants
with at least 1 first-degree relative (parent or sibling)
with documented allergic disease.
The following definitions are from various industry
sources:
Partially hydrolyzed (PH) formula: Contains reduced
oligopeptides that have a molecular weight of gener-
ally less than 5000 d (Table 1).
Extensively hydrolyzed (EH) formula: Contains only
peptides that have a molecular weight of less than
3000 d (Table 1).
Free amino acid––based formula: Peptide-free for-
mula that contains mixtures of essential and nones-
sential amino acids (Table 1).
DIETARY RESTRICTIONS FOR PREGNANT AND LACTATING
WOMEN
The earliest possible nutritional influence on atopic dis-
ease in an infant is the diet of the pregnant woman.
However, studies generally have not supported a protec-
tive effect of a maternal exclusion diet (including the
exclusion of cow milk and eggs) during pregnancy on
the development of atopic disease in infants, as summa-
rized in a 2006 Cochrane review.5–10 Although previous
AAP publications have suggested that pregnant women
avoid peanuts,3,11 a more recent study has reported that
there is no association between the maternal consump-
tion of peanuts during pregnancy and childhood peanut
allergy.12 Previous AAP publications have advised lactat-
ing mothers with infants at high risk of developing al-
lergy to avoid peanuts and tree nuts and to consider
eliminating eggs, cow milk, and fish from their diets
while nursing.3,11 Dietary food allergens can be detected
in breast milk, including peanuts, cow milk protein, and
egg.13–15 Two studies found a preventive effect of mater-
nal dietary exclusion of milk, egg, and fish while breast-
feeding on the development of atopic dermatitis in the
infant.16,17 Other studies found no association between
the development of atopic diseases and a maternal ex-
clusion diet.8,18,19 A 2003 study found no association
between breastfeeding and peanut allergy, and there
was no difference in peanut intake during lactation be-
tween mothers with and without children with peanut
allergy.12 Dietary food allergens in human milk may
interact with the mucosal immune system20 and induce
allergic reactions in infants who are known to be clini-
cally allergic to the antigen. Rare cases of anaphylaxis to
cow milk protein present in human milk have been
described even in exclusively breastfed infants.21
Consideration of a large number of studies on mater-
nal diet, not all of which were randomized or included
dietary restriction during lactation, demonstrated no im-
pact on various outcomes among the majority of the
studies, particularly when follow-up was beyond 4
years, and led one recent group of reviewers to conclude
that there is no convincing evidence for a long-term
preventive effect of maternal diet during lactation on
TABLE 1 Examples of Hydrolyzed Protein and Amino Acid–Based
Infant Formulas Available in the United States
Extensively hydrolyzed casein (cow milk protein)
Enfamil Nutramigen Lipil (Mead Johnson Nutritionals, Evansville, IN)
Enfamil Pregestimil (Mead Johnson Nutritionals)
Similac Alimentum Advance (Ross Products, Columbus, OH)
Partially hydrolyzed whey (cow milk protein)a
Good Start Supreme (Nestlé USA, Glendale, CA)
Partially hydrolyzed whey/casein (cow milk protein)a
Enfamil Gentlease Lipil (Mead Johnson Nutritionals)
Partially Hydrolyzed Soy (Soy Protein)
Good Start Supreme Soy (Nestlé USA)
Free amino acid–based
Neocate (and Neocate 1 for children12 mo) (Nutricia North America,
Gaithersburg, MD)
EleCare (Ross Pediatrics)
a For infants with known cowsmilk allergy, the residual milk protein peptides in these formulas
may cause an allergic reaction.
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atopic disease in childhood.22 A 2006 Cochrane review
also concluded that there was insufficient evidence that
antigen avoidance during lactation was beneficial in pre-
venting atopic disease in the breastfed infant, with the
exception of atopic dermatitis.5 Because the available
published trials have had methodologic shortcomings,
more data are necessary to conclude that the avoidance
of antigens during lactation prevents atopic dermatitis in
infants.5
ROLE OF HUMANMILK AND EXCLUSIVE BREASTFEEDING ON
THE DEVELOPMENT OF ATOPIC DISEASE
Since the 1930s, many studies have examined the benefits
of breastfeeding on the development of atopic disease. In
general, these have been nonrandomized, retrospective, or
observational in design and, thus, inconclusive.22,23 Of
course, it is not possible to truly randomize breastfeeding,
which is always a confounding variable in these studies.
Acknowledging this difficulty, Kramer23 proposed 12 crite-
ria to apply to studies designed to assess the relationship
between atopic disease and breastfeeding. These criteria
included nonreliance on late maternal recall of breastfeed-
ing, sufficient duration of exclusive breastfeeding, strict
diagnostic criteria for atopic outcomes, assessment of ef-
fects of children at high risk of atopic outcomes, and ade-
quate statistical power. Unfortunately, no studies to date
have completely fulfilled these criteria.
Atopic Dermatitis
A 2001 meta-analysis of 18 prospective studies com-
pared the incidence of atopic dermatitis in infants who
were breastfed versus infants who were fed cow milk
formula.24 Overall, there was a protective effect of ex-
clusive breastfeeding for 3 months (odds ratio [OR]:
0.68; 95% confidence interval [CI]: 0.52–0.88), the
stronger effect having been shown for infants with a
family history of allergy (OR: 0.58; 95% CI: 0.4–0.92).
No protective effect of breastfeeding was seen in children
who were not at risk of developing allergy (OR: 1.43;
95% CI: 0.72–2.86).24 A 2005 study published from Swe-
den25 found no effect of exclusive breastfeeding for 4
months on the incidence of atopic dermatitis in the first
year of life with or without a family history of atopic
disease. On the other hand, another 2005 study from
Sweden26 found that exclusive breastfeeding for more
than 4 months reduced the risk of atopic dermatitis at 4
years of age (OR: 0.78; 95% CI: 0.63–0.96) with or
without a family history of allergy. In their review,
Kramer and Kakuma27 also found no benefit of exclusive
breastfeeding beyond 3 months of age on the incidence
of atopic dermatitis in studies in which parents were not
selected for risk of allergy.
A series of recent reports from the German Infant
Nutritional Intervention Program28–30 also found that
breastfeeding reduces the incidence of atopic dermatitis,
supporting the results of the meta-analysis.24 In the in-
terventional arm of this study, 1834 newborn infants
identified as being at high risk of developing atopic dis-
ease were enrolled in a 3-year longitudinal, prospective
study. Breastfeeding infants at risk for atopic disease
were enrolled in the study before 14 days of life and, at
that time, were exclusively breastfed and had no history
of formula supplementation. Infants were randomly as-
signed at the time of entry to receive supplements of 1 of
3 hydrolyzed formulas (2 extensively hydrolyzed formu-
las and 1 partially hydrolyzed formula) or a cow milk
formula, if formula supplementation had begun. Eight
hundred eighty-nine mothers exclusively breastfed for 4
months and did not use any of the formula supplements
they were randomly assigned to use. Nine hundred
forty-five infants were introduced to the randomly as-
signed formula before 4 months and, thus, were not
exclusively breastfed. Of these, 689 infants were ran-
domly assigned to receive one of the hydrolyzed formu-
las, and 256 were randomly assigned to receive cowmilk
formula. The incidence of atopic dermatitis in infants
who were exclusively breastfed, breastfed with supple-
mental hydrolyzed formula, and breastfed with supple-
mental cow milk formula was 9.5%, 9.8%, and 14.8%,
respectively, at the 1-year follow-up.28–30 Thus, exclusive
breastfeeding for 4 months showed a positive effect com-
pared with breastfeeding with supplemental cow milk
formula in these infants at high risk of developing al-
lergy. Breastfeeding with supplemental hydrolyzed for-
mula (both partially and extensively hydrolyzed) also
showed a positive effect compared with breastfeeding
with supplemental cow milk formula; however, breast-
feeding with supplements of hydrolyzed formulas
showed no advantage compared with exclusive breast-
feeding. Both groups showed a one-third decrease in the
risk of atopic dermatitis compared with the risk of
breastfeeding with supplements of cow milk formula.
Thus, exclusive breastfeeding or breastfeeding with hy-
drolyzed formula is not enough to prevent the majority
of cases of atopic dermatitis.
The advantages of breastfeeding are less clear for in-
fants who are not selected for high risk of developing
atopic disease, as shown in the noninterventional arm of
the German Infant Nutritional Intervention Program.28
In this arm, mothers unselected for a history of atopy
who either formula fed or partially breastfed their in-
fants were free to select cow milk–based or hydrolyzed
formulas. No differences in the incidence of atopic der-
matitis occurred among the 3 groups of infants (exclu-
sively breastfed for 4 months, cow milk formula fed with
or without breastfeeding, and hydrolyzed formula fed
with or without breastfeeding). This lack of effect has
been attributed to reverse causation; thus, mothers who
knew that their infants were at risk of developing allergy
were more likely not only to breastfeed but also to
breastfeed for a longer period of time. Alternatively,
mothers who were not going to breastfeed or were going
to supplement with formula were more likely to choose
hydrolyzed formula if they believed that their children
were at risk of developing atopy. This reverse causation
effect may explain why some studies have found an
increased incidence of atopic dermatitis in breastfed in-
fants.31–33
In summary, for infants at high risk of developing
atopy, there is evidence that exclusive breastfeeding for
at least 4 months or breastfeeding with supplements of
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hydrolyzed infant formulas decreases the risk of atopic
dermatitis compared with breastfeeding with supple-
ments of standard cow milk–based formulas. On the
basis of currently available evidence, this is less likely to
apply to infants who are not at risk of developing atopy,
and exclusive breastfeeding beyond 3 to 4 months does
not seem to lead to any additional benefit in the inci-
dence of atopic eczema.27
Asthma
The evidence for the protective effects of human milk on
the development of asthma is more controversial. A
2001 meta-analysis of 12 prospective studies that met
preestablished criteria found that exclusive breastfeeding
for at least 3 months was protective against the devel-
opment of asthma between 2 and 5 years of age (OR:
0.70; 95% CI: 0.60–0.81).34 The effect of breastfeeding
was even stronger when the analysis was limited to
children from families with a history of atopic disease
(OR: 0.52; 95% CI: 0.35–0.79). No benefit was seen in
children from families without a history of atopic disease
(OR: 0.99; 95% CI: 0.48–2.03).34 Two more studies35,36
not included in this meta-analysis supported these re-
sults. On the other hand, a 2002 Cochrane review found
no benefit of exclusive breastfeeding beyond 3 months
on the incidence of asthma in families not preselected for
a history of atopic disease.27
Two additional reports in the literature with a more
accurate definition of asthma37,38 made a distinction be-
tween the wheezy bronchitis associated with viral infec-
tions in younger children and that of the allergic disease
seen in older children associated with respiratory spiro-
metric changes. In the first of these studies, a cohort of
1246 children in Tucson, Arizona, was followed from
birth to 13 years of age.37 The study found that an
association between breastfeeding and asthma at 13
years of age depended on the presence of maternal
asthma in children with atopic disease. Infants whose
mothers had asthma were at greatest risk of developing
asthma by 13 years of age if they had been breastfed
exclusively for 4 months (OR: 8.7; 95% CI: 3.4–22.2).
When infants with atopic disease whose mothers had
asthma were exclusively breastfed for any length of time
(either greater than or less than 4 months), the risk of
developing asthma between 6 and 13 years of age was
also increased (OR: 5.7; 95% CI: 2.3–14.1). An increased
risk of developing asthma was not found in breastfed
children of mothers without asthma. However, in this
same study during the first 2 years of life, exclusive
breastfeeding was associated with significantly lower
rates of recurrent wheezing of infancy (OR: 0.45; 95%
CI: 0.2–0.9), similar to results from a recent study per-
formed in Perth, Australia.35
In the second of these studies, a long-term longitudi-
nal study from New Zealand,38 1037 children from a
general population (not selected for risk of allergic dis-
ease) were followed from 3 to 26 years of age. Five
hundred four infants were breastfed for 4 weeks or
more, and 533 infants were formula fed from the time of
birth or breastfed for less than 4 weeks. Breastfeeding for
more than 4 weeks significantly increased the risk of
developing asthma at 9 years (OR: 2.40; 95% CI: 1.36–
4.6) and at 21 years (OR: 1.83; 95% CI: 1.35–2.47). This
increased risk was not related to the presence of mater-
nal atopic disease, unlike in the Tucson study. The study
has been criticized for retrospective determination of
breastfeeding and unclear definitions of atopic heredi-
ty.22 There was also no evidence of a “dose-response”
effect of breastfeeding on the incidence of atopy or
asthma.
In summary, at the present time, it is not possible to
conclude that exclusive breastfeeding protects young in-
fants who are at risk of atopic disease from developing
asthma in the long term (6 years of age), and it may
even have a detrimental effect.37,38 On the other hand,
breastfeeding seems to decrease the wheezing episodes
seen in younger children (4 years of age) that are often
associated with respiratory infections.35,36
Food Allergy
Food allergy, similar to atopic dermatitis and asthma, is
more likely to occur in infants with a family history of
atopic disease. In a prospective study of infants born to
families with a history of atopic disease, it was determined
that 25% will develop food allergy between birth and 7
years of age.39 Because both atopic dermatitis and asthma
are closely associatedwith the development of food allergy,
it is difficult to sort out the effect of breastfeeding on the
development of food allergy. As reviewed above, maternal
dietary exposure during pregnancy and lactation is un-
likely to contribute significantly to the development of food
allergy in the infant, although many food antigens can be
found in human milk. In theory, human milk should in-
hibit food antigen absorption; however, prospective studies
have failed to show a protective effect of human milk–
specific antibodies to cow milk on infant sensitization.40
Investigations of the role of breastfeeding on the outcomes
of allergies to specific foods have been few, and the results
may have been influenced by additional dietary variables
such as length and degree of breastfeeding exclusivity. In
reviewing the available studies, Muraro et al22 concluded
that exclusively breastfeeding for at least 4 months in in-
fants who are at risk of developing atopic diseases is asso-
ciated with a lower cumulative incidence of cow milk
allergy until 18 months of age. A Cochrane review
included only 1 study with a blinded challenge (using
the double-blind, placebo-controlled food-challenge tech-
nique) and concluded that at least 4 months of exclusive
breastfeeding did not protect against food allergy at 1 year
of age.27 Overall, firm conclusions about the role of breast-
feeding in either preventing or delaying the onset of spe-
cific food allergies are not possible at this time.
ROLE OF HYDROLYZED FORMULA ON THE DEVELOPMENT OF
ATOPIC DISEASE
The role of partially hydrolyzed and extensively hydro-
lyzed formulas for the prevention of atopic disease has
been the subject of many studies in both formula-fed
and breastfed infants in the last 15 years. Most studies
with published results have been of infants at high risk
of developing allergy.
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Approximately 100 studies in the literature have ex-
amined the role of hydrolyzed formulas on the develop-
ment of atopic disease. However, using the criteria of a
2006 Cochrane review,41 only 14 randomized or quasi-
randomized (eg, using alternation) trials in term infants
compared the use of partially or extensively hydrolyzed
formula with the use of human milk or an adapted cow
milk formula.42–55 All of these trials have followed up
with at least 80% of study participants. It is important to
note that none of these studies reported any adverse
effects, including any adverse effect on infant growth.
No long-term studies have compared partially or exten-
sively hydrolyzed formula to exclusive breastfeeding.
Thus, there is no evidence that the use of these formulas
is any better than human milk in the prevention of
atopic disease.
Three studies of 251 infants examined the effect of
partially hydrolyzed formula on reduction of the occur-
rence of any allergy compared with cow milk formula in
infants at high risk of developing allergy.49,51,52 Two of
these studies found no significant effect,51,52 and a third
study found an OR of 0.45 (95% CI: 0.22–0.94) for
partially hydrolyzed formula versus cow milk formula.49
Three more studies53–55 examined prolonged feeding of
extensively hydrolyzed formula compared with partially
hydrolyzed formula in 411 infants at high risk of devel-
oping allergy. None of these studies found a significant
difference in the incidence of atopic dermatitis between
the 2 feeding groups. Two of these studies53,55 of 352
infants also examined other manifestations of atopic dis-
ease and did not show a significant difference in the
occurrence of food allergy, cow milk allergy, or asthma
between the groups of infants who were fed extensively
or partially hydrolyzed formula.
A very large published study from the German Infant
Nutritional Intervention Program30 raised additional is-
sues. In the interventional arm of this study, 945 new-
born infants were identified as being at high risk of
developing atopic disease and were enrolled in a longi-
tudinal, prospective study through 12 months of age.
Although the majority of infants were breastfed initially,
formula was introduced in the first 4 weeks to most
infants. The infants were randomly assigned to receive 1
of 3 hydrolyzed formulas (n  689) or cow milk formula
(n  256). The 3 hydrolyzed formulas were a partially
hydrolyzed whey-based formula, an extensively hydro-
lyzed whey-based formula, and an extensively hydro-
lyzed casein-based formula. The incidence of atopic der-
matitis was significantly reduced in those using the
extensively hydrolyzed casein-based formula (OR: 0.42;
95% CI: 0.22–0.79; P  .007) and the partially hydro-
lyzed whey-based formula (OR: 0.56; 95% CI: 0.32–
0.99; P  .046) but not the extensively hydrolyzed
whey-based formula (OR: 0.81; 95% CI: 0.48–1.4; P 
.44), compared with the incidence in those in the cow
milk formula group. However, the overall results for
prevention of allergic disease (atopic dermatitis, urti-
caria, and food allergy) for the 3 hydrolyzed formulas
compared with cow milk formula were less impressive
(extensively hydrolyzed whey-based: OR: 0.86; 95% CI:
0.52–1.4; partially hydrolyzed whey-based: OR: 0.65;
95% CI: 0.38–1.1; and extensively hydrolyzed casein-
based: OR: 0.51; 95% CI: 0.28–0.92; P  .025). Thus,
this study indicated that different hydrolysates have dif-
ferent effects on atopic disease, and there may be an
advantage for the extensively hydrolyzed casein-based
formula. However, as the study demonstrated, it is dif-
ficult to show that partially hydrolyzed formulas have a
very large effect on the reduction of atopic disease in
infants who are fed formula or mixed feedings of human
milk and formula, even if they are at high risk of devel-
oping allergic disease. If atopic disease associated with
cow milk allergy has occurred, partially hydrolyzed for-
mula is not recommended, because it contains poten-
tially allergic cow milk peptides.
More studies are needed to determine if any of the
hydrolyzed formulas have any effect on the incidence of
atopic disease later in childhood and adolescence and
whether the modest effects of the use of extensively or
partially hydrolyzed formulas in early childhood can be
confirmed and are sustained. Such studies should also
include a cost/benefit analysis of the use of the more
expensive hydrolyzed formulas. It should be noted that
the potential benefit of these formulas has only been
documented in infants at risk of developing atopic dis-
ease. Additional studies are needed among unselected
infants or infants at low risk.
The use of amino acid–based formulas for prevention
of atopic disease has not been studied. Soy formulas, on
the other hand, have a long history of use for atopic
disease in infants. In a recent meta-analysis of 5 random-
ized or quasi-randomized studies, the authors concluded
that feeding with soy formula should not be recom-
mended for the prevention of atopy in infants at high
risk of developing allergy.56
ROLE OF INTRODUCTION OF COMPLEMENTARY FOODS ON
ATOPIC DISEASE
Many studies have examined the duration of breastfeed-
ing and its effect on atopic disease. However, few studies
have examined the timing of the introduction of com-
plementary foods as an independent risk factor for atopic
disease in breastfed or formula-fed infants. An expert
panel from the European Academy of Allergology and
Clinical Immunology has recommended delayed intro-
duction of solid foods for 4 to 6 months in breastfed or
formula-fed infants.22 The AAP has also recommended
that solid foods be delayed until 4 to 6 months of age and
that whole cowmilk be delayed until 12 months of age.11
Before publication of this clinical report, AAP recom-
mendations for infants who are at risk of developing
atopic disease were to avoid eggs until 2 years of age and
avoid peanuts, tree nuts, and fish until 3 years of age.3,11
These guidelines for solid food introduction and avoid-
ance of specific allergens were based on the evidence of
a few studies with various limitations.39,57–59 Three newer
studies have reported mixed results regarding the timing
of the introduction of solid foods and development of
childhood atopic disease.60–62
In a prospective (nonrandomized) study of infants at
risk of developing atopic disease by Kajosaari57, atopic
dermatitis and history of food allergy were reduced at 1
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year of age if the introduction of solid foods was delayed
until 6 months compared with at 3 months of age.
However, in a 5-year follow-up study, no difference was
seen in the incidence of atopic dermatitis or symptoms of
food allergy.57 In a second prospective study of a birth
cohort of 1210 unselected children between 2 and 4
years of age, there was more atopic dermatitis but not
asthma in infants who were fed 4 or more solid foods
compared with no solid foods before 4 months of age.58
This difference was maintained in a 10-year follow-up
study in 85% of the original study infants.59
In a study of 257 preterm infants (34.4 weeks’ gesta-
tional age; birth weight: 2.3–2.4 kg), the introduction of
4 or more, compared with fewer than 4, solid foods
before 17 weeks after term was associated with a higher
risk of atopic dermatitis (unconfirmed by skin-prick test-
ing) at 12 months after term (OR: 3.49; 95% CI: 1.51–
8.05).60 Also in this study, the introduction of solid foods
before 10 weeks of age or atopic disease in either parent
increased the risk of atopic dermatitis in infants (OR:
2.94; 95% CI: 1.57–5.52). In a more recent prospective,
longitudinal cohort study in which atopic dermatitis was
confirmed by skin testing, 642 infants were followed
until 5.5 years of age.61 The history of the introduction of
solid foods was carefully recorded during the first year of
life. Most children had at least 1 parent with a positive
skin-prick test result. Rice cereal was introduced at a
median age of 3 months, milk was introduced at a me-
dian age of 6 months, and egg was introduced at a
median age of 8 months. However, the later introduc-
tion of solids had no effect on the prevalence of asthma
or atopic dermatitis (confirmed by skin-prick testing),
although there was an increased risk of atopic dermatitis
in relation to the late (6–8 months) rather than the
earlier introduction of eggs (OR: 1.6; 95% CI: 1.1–2.4) or
milk (OR: 1.7; 95% CI: 1.1–2.5).61
Finally, an ongoing prospective, cohort study62 of
2612 infants (without a risk of developing atopic dis-
ease) found no evidence to support delayed introduction
of solid foods beyond 6 months of age for prevention of
atopic disease. However, in the same study, the effect of
delayed introduction of solid foods for the first 4 months
of life was less clear. Another study has even suggested
that children exposed to cereal grains before 6 months of
age (as opposed to after 6 months of age) are protected
from the development of wheat-specific IgE.63
In summary, the evidence from these conflicting
studies, in balance, does not allow one to conclude that
there is a strong relationship between the timing of the
introduction of complementary foods and development
of atopic disease. This raises serious questions about the
benefit of delaying the introduction of solid foods that
are thought to be highly allergic (cow milk, fish, eggs,
and peanut-containing foods) beyond 4 to 6 months of
age; additional studies are needed.
SUMMARY
It is evident that inadequate study design and/or a pau-
city of data currently limit the ability to draw firm con-
clusions about certain aspects of atopy prevention
through dietary interventions. In some circumstances in
which there are insufficient studies (pregnancy and lac-
tation avoidance diets, timing of introduction of specific
complementary foods), the lack of proven efficacy does
not indicate that the approach is disproved. Rather,
more studies would be needed to clarify whether there is
a positive or negative effect on atopy outcomes. The
following statements summarize the current evidence
within the context of these limitations.
1. At the present time, there is lack of evidence that
maternal dietary restrictions during pregnancy play a
significant role in the prevention of atopic disease in
infants. Similarly, antigen avoidance during lactation
does not prevent atopic disease, with the possible
exception of atopic eczema, although more data are
needed to substantiate this conclusion.
2. For infants at high risk of developing atopic disease,
there is evidence that exclusive breastfeeding for at
least 4 months compared with feeding intact cow
milk protein formula decreases the cumulative inci-
dence of atopic dermatitis and cow milk allergy in the
first 2 years of life.
3. There is evidence that exclusive breastfeeding for at
least 3 months protects against wheezing in early life.
However, in infants at risk of developing atopic dis-
ease, the current evidence that exclusive breastfeed-
ing protects against allergic asthma occurring beyond
6 years of age is not convincing.
4. In studies of infants at high risk of developing atopic
disease who are not breastfed exclusively for 4 to 6
months or are formula fed, there is modest evidence
that atopic dermatitis may be delayed or prevented by
the use of extensively or partially hydrolyzed formu-
las, compared with cow milk formula, in early child-
hood. Comparative studies of the various hydrolyzed
formulas have also indicated that not all formulas
have the same protective benefit. Extensively hydro-
lyzed formulas may be more effective than partially
hydrolyzed in the prevention of atopic disease. In
addition, more research is needed to determine
whether these benefits extend into late childhood
and adolescence. The higher cost of the hydrolyzed
formulas must be considered in any decision-making
process for their use. To date, the use of amino acid–
based formulas for atopy prevention has not been
studied.
5. There is no convincing evidence for the use of soy-
based infant formula for the purpose of allergy pre-
vention.
6. Although solid foods should not be introduced before
4 to 6 months of age, there is no current convincing
evidence that delaying their introduction beyond this
period has a significant protective effect on the devel-
opment of atopic disease regardless of whether in-
fants are fed cow milk protein formula or human
milk. This includes delaying the introduction of foods
that are considered to be highly allergic, such as fish,
eggs, and foods containing peanut protein.
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7. For infants after 4 to 6 months of age, there are
insufficient data to support a protective effect of any
dietary intervention for the development of atopic
disease.
8. Additional studies are needed to document the long-
term effect of dietary interventions in infancy to pre-
vent atopic disease, especially in children older than 4
years and in adults.
9. This document describes means to prevent or delay
atopic diseases through dietary changes. For a child
who has developed an atopic disease that may be
precipitated or exacerbated by ingested proteins (via
human milk, infant formula, or specific complemen-
tary foods), treatment may require specific identifica-
tion and restriction of causal food proteins. This topic
was not reviewed in this document.
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